Skip to content

Pain Due to Peripheral Intravenous Catheter Insertion

The Effect of Rose Oil Aromatherapy and Hand-Holding on Pain Due to Peripheral Intravenous Catheter Insertion: A Mixed Method Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05425849
Enrollment
126
Registered
2022-06-21
Start date
2021-04-10
Completion date
2021-09-10
Last updated
2022-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

This study aimed to evaluate the effectiveness of rose oil aromatherapy and hand-holding in reducing pain associated with peripheral intravenous catheters (PIVCs) insertion. Study Hypothesis: H0-1. The application of rose oil aromatherapy during the PIVC insertion procedure does not reduce the pain associated with the procedure. H0-2. During the PIVC insertion procedure, the patient's family holding the patient's hand does not reduce the pain associated with the procedure.

Interventions

OTHERrose oil aromatherapy

Aromatherapy refers to the medicinal or therapeutic use of essential oils absorbed through the skin or the olfactory system. The positive effects of social support, such as hand-holding, on anxiety and pain have been described

Sponsors

Saglik Bilimleri Universitesi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* patients voluntarily accepted to participate in the study, * aged between 18-65, * Turkish literate, * PIVC placement planned, * no hematoma, ecchymosis, scar and sensory change in the antecubital region, * suitable for PIVC insertion with a 20 gauge (pink) catheter in the antecubital region, * who did not take analgesic drugs for 24 hours and were accompanied by a member of the patient's family (spouse or child). * patients with an Enhanced Adult DIVA (EA-DIVA) score below 8 for PIVC placement in a single intervention, * the STAI score below 40

Exclusion criteria

* sensitive to smell and had problems in smelling, * patients with epilepsy, asthma diagnosis, * patients with a history of allergy

Design outcomes

Primary

MeasureTime frameDescription
Pain Score1 minute-10 minutesNumeric Rating Scale was used. The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026